UnitedHealth Group Reports 2017 Results Highlighted by Continued Strong and Diversified Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
UnitedHealth Group (UNH) PT Raised to $260 at Oppenheimer Following 4Q
January 17, 2018 9:37 AM ESTOppenheimer raised its price target on UnitedHealth Group (NYSE: UNH) to $260.00 (from $240.00) while maintaining a Outperform rating following the company's 4Q earnings report. UNH reported 4Q17 adj. EPS of $2.59 vs. the Street's estimates of $2.51. The key topic of discussion was the impact of... More
UnitedHealth Group (UNH) PT Raised to $275 at BMO Capital; 'Tax Reform Upside, Risk Retrenchment and Growth'
January 17, 2018 9:10 AM ESTBMO Capital raised its price target on UnitedHealth Group (NYSE: UNH) to $275.00 (from $250.00) while maintaining a Outperform rating.
Analyst Matt Borsch commented, "We are bullish on UNH stock as the company posted another solid quarter while guiding to a stronger-than-expected... More
UnitedHealth Group (UNH) PT Raised to $259 at Piper Jaffray; Remains Bullish
January 17, 2018 7:15 AM ESTPiper Jaffray raised its price target on UnitedHealth Group (NYSE: UNH) to $259.00 (from $242.00) while maintaining a Overweight rating. Analyst Sarah James still sees 2018/2019 estimates as conservative with potential for 3%+ upside to 2019 estimates should the company continue to see similar growth rates in Optum,... More

